Aker BioMarine ASA (OSE:AKBM) has today notified Nordic Trustee AS of the
exercise of its call option for the outstanding bonds in the bond issue "FRN
Senior Secured NOK 2,000,000,000 Bonds 2024/2027" (ISIN NO0013326025), and each
Bondholder is hereby given notice thereof. 

The exercise of the call option is conditional upon certain conditions as set
out in the Call Option Notice being satisfied or waived no later than by 25
March 2026. 

Subject to satisfaction of the aforementioned conditions by no later than 25
March 2026, the entire bond issue will be repaid at 102.125% of the Nominal
Amount (plus accrued and unpaid interests on the redeemed amount), with
settlement date 30 March 2026 (being the date falling 10 Business Days after the
date of the Call Option Notice). 

For information relating to the exercise of the Call Option, reference is made
to the attached call notice. 

For further information, please contact 
Katrine Klaveness, CFO
Mobile: +47 991 58 915
Email:  Katrine.klaveness@akerbiomarine.com  

This information is subject to the disclosure requirements pursuant to MAR
Article 19 and Section 5-12 of the Norwegian Securities Trading Act. 

About Aker BioMarine: 
Aker BioMarine is a leading human health and nutrition innovator that develops
krill-derived products for consumer health and nutrition. Krill is a natural,
powerful, and health-promoting source of nutrients from the pristine waters of
Antarctica, and Aker BioMarine has a unique position in its industry. The
ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+,
as well as the consumer brand, Kori Krill. The innovative approach also extends
into the spin-offs AION (reduce and recycle plastic waste across industries) and
Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock
Exchange (AKBM). More information is available at www.akerbiomarine.com.